(-)-OSU6162 reduces freezing elicited by context-conditioned fear in rats

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• (-)-OSU6162 acts as a dopaminergic D2 receptor antagonist, typically reducing activity in novel environments.
• Uniquely, (-)-OSU6162 stimulates locomotor activity in habituated rodents, suggesting a complex behavioral profile.
• The involvement of serotonergic 5-HT2A and sigma-1 receptors in (-)-OSU6162's atypical effects remains unclear.

Purpose of the Study:

• To investigate the effect of (-)-OSU6162 on freezing behavior in rats experiencing context-conditioned fear.
• To compare the efficacy of (-)-OSU6162 with amphetamine, a known dopamine-augmenting agent, in the same fear paradigm.
• To determine if D2, 5-HT2A, or sigma-1 receptors mediate the observed behavioral effects of (-)-OSU6162.

Main Methods:

• Rats underwent contextual fear conditioning via electrical foot shocks.
• The impact of (-)-OSU6162 and amphetamine on freezing behavior was assessed.
• Pretreatment with D2/D3 antagonist (raclopride), 5-HT2A inverse agonist (MDL100907), or sigma-1 antagonist (BD1063) was used to probe receptor involvement.

Main Results:

• (-)-OSU6162 significantly reduced freezing behavior, while amphetamine completely abolished it.
• The anti-freezing effect of (-)-OSU6162 was reversed by raclopride.
• MDL100907 and BD1063 did not counteract the effects of (-)-OSU6162.

Conclusions:

• (-)-OSU6162 effectively reduces context-conditioned fear, manifesting as decreased freezing behavior.
• The mechanism underlying (-)-OSU6162's anti-fear effect involves dopaminergic D2 receptors.
• Serotonergic 5-HT2A and sigma-1 receptors are not implicated in (-)-OSU6162's modulation of fear-related freezing.